Betatrophin: no relation to glucose metabolism or weight status in obese children before and after lifestyle intervention

The influences of obesity, glucose metabolism, gender, and puberty on betatrophin levels and the longitudinal relationships between weight loss, metabolic changes and betatrophin have not yet been studied in childhood.

[1]  J. Martínez,et al.  Interplay of atherogenic factors, protein intake and betatrophin levels in obese–metabolic syndrome patients treated with hypocaloric diets , 2016, International Journal of Obesity.

[2]  Cai-e Zhang,et al.  Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance , 2016, Pediatric diabetes.

[3]  H. J. Yoo,et al.  Circulating angiopoietin-like protein 8 (ANGPTL8) and ANGPTL3 concentrations in relation to anthropometric and metabolic profiles in Korean children: a prospective cohort study , 2016, Cardiovascular Diabetology.

[4]  Fuqiang Liu,et al.  Circulating Levels of Betatrophin and Irisin Are Not Associated with Pancreatic β-Cell Function in Previously Diagnosed Type 2 Diabetes Mellitus Patients , 2015, Journal of diabetes research.

[5]  M. Martinell,et al.  Betatrophin in Diabetes Mellitus: the Epidemiological Evidence in Humans , 2015, Current Diabetes Reports.

[6]  P. Klimek,et al.  Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus , 2015, PloS one.

[7]  X. Estivill,et al.  Circulating Betatrophin Levels Are Increased in Anorexia and Decreased in Morbidly Obese Women. , 2015, The Journal of clinical endocrinology and metabolism.

[8]  J. Kushner,et al.  Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice , 2015, Diabetologia.

[9]  Y. Yeh,et al.  Emerging Regulation and Function of Betatrophin , 2014, International journal of molecular sciences.

[10]  Jonathan C. Cohen,et al.  ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell Expansion , 2014, Cell.

[11]  A. Abou-Samra,et al.  A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy , 2014, Cardiovascular Diabetology.

[12]  Libin Zhou,et al.  Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients , 2014, Diabetes Care.

[13]  A. Abou-Samra,et al.  An explanation for recent discrepancies in levels of human circulating betatrophin , 2014, Diabetologia.

[14]  G. Frühbeck,et al.  Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. , 2014, The Journal of clinical endocrinology and metabolism.

[15]  B. Seyoum,et al.  Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity , 2014, Scientific Reports.

[16]  M. Martinell,et al.  Increased Circulating Betatrophin Concentrations in Patients with Type 2 Diabetes , 2014, International journal of endocrinology.

[17]  A. Kautzky-Willer,et al.  Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals , 2014, Diabetologia.

[18]  K. Kaestner,et al.  Elevated Mouse Hepatic Betatrophin Expression Does Not Increase Human β-Cell Replication in the Transplant Setting , 2014, Diabetes.

[19]  Jonathan C. Cohen,et al.  Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis , 2013, Proceedings of the National Academy of Sciences.

[20]  D. Melton,et al.  RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation , 2013, Cell.

[21]  A. Wagers,et al.  Liver-derived systemic factors drive β cell hyperplasia in insulin-resistant states. , 2013, Cell reports.

[22]  T. Reinehr,et al.  Brain-derived neurotrophic factor and its relation to leptin in obese children before and after weight loss. , 2013, Metabolism: clinical and experimental.

[23]  Jonathan C. Cohen,et al.  Atypical angiopoietin-like protein that regulates ANGPTL3 , 2012, Proceedings of the National Academy of Sciences.

[24]  Ren Zhang,et al.  Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. , 2012, Biochemical and biophysical research communications.

[25]  Ji Young Kim,et al.  Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. , 2012, American journal of physiology. Endocrinology and metabolism.

[26]  T. Reinehr,et al.  Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. , 2012, The Journal of clinical endocrinology and metabolism.

[27]  Li Li,et al.  A mouse knockout library for secreted and transmembrane proteins , 2010, Nature Biotechnology.

[28]  J. Hebebrand,et al.  Changes of peripheral alpha-melanocyte-stimulating hormone in childhood obesity. , 2010, Metabolism: clinical and experimental.

[29]  E. Ford,et al.  Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. , 2008, The Journal of pediatrics.

[30]  J. Hebebrand,et al.  Definable somatic disorders in overweight children and adolescents. , 2007, The Journal of pediatrics.

[31]  T. Reinehr,et al.  Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. , 2006, The American journal of clinical nutrition.

[32]  B. Rosner,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents , 2004 .

[33]  Isabel Rey Madeira,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. , 2004, Pediatrics.

[34]  S. Trost,et al.  Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. , 2004, Diabetes care.

[35]  J. Yanovski,et al.  Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. , 2002, Diabetes care.

[36]  T. Cole,et al.  Establishing a standard definition for child overweight and obesity worldwide: international survey , 2000, BMJ : British Medical Journal.

[37]  I. Deary,et al.  Insulin resistance , 1996 .

[38]  C. Lenfant,et al.  National High Blood Pressure Education Program. , 1986, Journal of the American Optometric Association.

[39]  Robert Walgate,et al.  Proliferation , 1985, Nature.

[40]  Daowen Wang,et al.  Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. , 2015, The Journal of clinical endocrinology and metabolism.

[41]  T. Cole.  The LMS method for constructing normalized growth standards. , 1990, European journal of clinical nutrition.